KLRK1 and central nervous system cancer: Accordingly, we examined differences in NKG2D expression on CD8+ T cells infiltrating either CT2A-TRP2 or CT2A-TRP2-β2mKO gliomas in untreated mice or in mice treated with αPD-1/4-1BB.